Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1975 3
1977 1
1978 1
1979 1
1980 1
1981 1
1982 1
1983 6
1984 10
1985 7
1986 7
1987 9
1988 5
1989 13
1990 8
1991 4
1992 8
1993 12
1994 12
1995 11
1996 14
1997 14
1998 15
1999 18
2000 18
2001 14
2002 13
2003 28
2004 18
2005 31
2006 31
2007 34
2008 40
2009 39
2010 43
2011 36
2012 54
2013 60
2014 71
2015 80
2016 74
2017 78
2018 97
2019 85
2020 109
2021 110
2022 102
2023 96
2024 52

Text availability

Article attribute

Article type

Publication date

Search Results

1,371 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hypertrophic cardiomyopathy 8"
Page 1
Diagnostic yield of genetic testing in a heterogeneous cohort of 1376 HCM patients.
Hathaway J, Heliö K, Saarinen I, Tallila J, Seppälä EH, Tuupanen S, Turpeinen H, Kangas-Kontio T, Schleit J, Tommiska J, Kytölä V, Valori M, Muona M, Sistonen J, Gentile M, Salmenperä P, Myllykangas S, Paananen J, Alastalo TP, Heliö T, Koskenvuo J. Hathaway J, et al. BMC Cardiovasc Disord. 2021 Mar 5;21(1):126. doi: 10.1186/s12872-021-01927-5. BMC Cardiovasc Disord. 2021. PMID: 33673806 Free PMC article.
BACKGROUND: Genetic testing in hypertrophic cardiomyopathy (HCM) is a published guideline-based recommendation. ...RESULTS: A total of 1376 samples were analyzed. Three hundred and sixty-nine tests were diagnostic (26.8%); 373 P or LP variants were identified …
BACKGROUND: Genetic testing in hypertrophic cardiomyopathy (HCM) is a published guideline-based recommendation. ...RESULTS: A …
Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy.
Lopes LR, Syrris P, Guttmann OP, O'Mahony C, Tang HC, Dalageorgou C, Jenkins S, Hubank M, Monserrat L, McKenna WJ, Plagnol V, Elliott PM. Lopes LR, et al. Heart. 2015 Feb;101(4):294-301. doi: 10.1136/heartjnl-2014-306387. Epub 2014 Oct 28. Heart. 2015. PMID: 25351510 Free PMC article.
OBJECTIVE: A predictable relation between genotype and disease expression is needed in order to use genetic testing for clinical decision-making in hypertrophic cardiomyopathy (HCM). ...Variants in SP and non-SP genes were tested for associations with phenoty …
OBJECTIVE: A predictable relation between genotype and disease expression is needed in order to use genetic testing for clinical deci …
Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines.
Wang J, Yang S, Ma X, Zhao K, Yang K, Yu S, Yin G, Dong Z, Song Y, Cui C, Li J, Wang C, Hao J, Lu M, Chen X, Zhao S. Wang J, et al. Eur Heart J. 2023 Dec 1;44(45):4781-4792. doi: 10.1093/eurheartj/ehad581. Eur Heart J. 2023. PMID: 37795986
BACKGROUND AND AIMS: Identifying patients with hypertrophic cardiomyopathy (HCM) who are candidates for implantable cardioverter defibrillator (ICD) implantation in primary prevention for sudden cardiac death (SCD) is crucial. ...Compared with the 2014 ESC model, th …
BACKGROUND AND AIMS: Identifying patients with hypertrophic cardiomyopathy (HCM) who are candidates for implantable cardiovert …
Genome-wide association analysis of left ventricular imaging-derived phenotypes identifies 72 risk loci and yields genetic insights into hypertrophic cardiomyopathy.
Ning C, Fan L, Jin M, Wang W, Hu Z, Cai Y, Chen L, Lu Z, Zhang M, Chen C, Li Y, Zhang F, Wang W, Liu Y, Chen S, Jiang Y, He C, Wang Z, Chen X, Li H, Li G, Ma Q, Geng H, Tian W, Zhang H, Liu B, Xia Q, Yang X, Liu Z, Li B, Zhu Y, Li X, Zhang S, Tian J, Miao X. Ning C, et al. Nat Commun. 2023 Nov 30;14(1):7900. doi: 10.1038/s41467-023-43771-5. Nat Commun. 2023. PMID: 38036550 Free PMC article.
Left ventricular regional wall thickness (LVRWT) is an independent predictor of morbidity and mortality in cardiovascular diseases (CVDs). ...Significant causal relationships were observed between the LVRWT traits and hypertrophic cardiomyopathy (HCM) …
Left ventricular regional wall thickness (LVRWT) is an independent predictor of morbidity and mortality in cardiovascular diseases (C …
Hypokinetic hypertrophic cardiomyopathy: clinical phenotype, genetics, and prognosis.
Wasserstrum Y, Larrañaga-Moreira JM, Martinez-Veira C, Itelman E, Lotan D, Sabbag A, Kuperstein R, Peled Y, Freimark D, Barriales-Villa R, Arad M. Wasserstrum Y, et al. ESC Heart Fail. 2022 Aug;9(4):2301-2312. doi: 10.1002/ehf2.13914. Epub 2022 Apr 30. ESC Heart Fail. 2022. PMID: 35488723 Free PMC article.
AIMS: To describe the phenotype, genetics, and events associated with the development of hypertrophic cardiomyopathy (HCM) with reduced ventricular function (HCMr). ...Patients who developed HCMr in the course of the study had similar mortality but a higher rate of …
AIMS: To describe the phenotype, genetics, and events associated with the development of hypertrophic cardiomyopathy (HCM) wit …
Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy.
Norrish G, Cleary A, Field E, Cervi E, Boleti O, Ziółkowska L, Olivotto I, Khraiche D, Limongelli G, Anastasakis A, Weintraub R, Biagini E, Ragni L, Prendiville T, Duignan S, McLeod K, Ilina M, Fernandez A, Marrone C, Bökenkamp R, Baban A, Kubus P, Daubeney PEF, Sarquella-Brugada G, Cesar S, Klaassen S, Ojala TH, Bhole V, Medrano C, Uzun O, Brown E, Gran F, Sinagra G, Castro FJ, Stuart G, Yamazawa H, Barriales-Villa R, Garcia-Guereta L, Adwani S, Linter K, Bharucha T, Gonzales-Lopez E, Siles A, Rasmussen TB, Calcagnino M, Jones CB, De Wilde H, Kubo T, Felice T, Popoiu A, Mogensen J, Mathur S, Centeno F, Reinhardt Z, Schouvey S, Elliott PM, Kaski JP. Norrish G, et al. J Am Coll Cardiol. 2022 May 24;79(20):1986-1997. doi: 10.1016/j.jacc.2022.03.347. J Am Coll Cardiol. 2022. PMID: 35589160 Free PMC article.
BACKGROUND: Up to one-half of childhood sarcomeric hypertrophic cardiomyopathy (HCM) presents before the age of 12 years, but this patient group has not been systematically characterized. OBJECTIVES: The aim of this study was to describe the clinical presentation an …
BACKGROUND: Up to one-half of childhood sarcomeric hypertrophic cardiomyopathy (HCM) presents before the age of 12 years, but …
Clinical prediction of genotypes in hypertrophic cardiomyopathy: A systematic review.
Aziz A, Musiol SK, Moody WE, Pickup L, Cooper R, Lip GYH. Aziz A, et al. Eur J Clin Invest. 2021 Aug;51(8):e13593. doi: 10.1111/eci.13593. Epub 2021 May 25. Eur J Clin Invest. 2021. PMID: 33948946
INTRODUCTION: Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac condition and the most common cause of sudden cardiac death (SCD) in patients below the age of 35. ...Two externally validated scoring systems have also been developed …
INTRODUCTION: Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac condition and the most common cause of su …
Latent outflow tract obstruction in hypertrophic cardiomyopathy: Clinical characteristics and outcomes of septal myectomy.
Cui H, Schaff HV, Nishimura RA, Dearani JA, Geske JB, Ommen SR. Cui H, et al. J Thorac Cardiovasc Surg. 2022 Dec;164(6):1863-1869.e1. doi: 10.1016/j.jtcvs.2020.12.016. Epub 2020 Dec 10. J Thorac Cardiovasc Surg. 2022. PMID: 33468328 Review.
OBJECTIVE: This investigation analyzed clinical characteristics of patients with hypertrophic cardiomyopathy (HCM) and latent left ventricular outflow tract (LVOT) and outcomes following septal myectomy. ...Patients with latent obstruction were more likely to be mal …
OBJECTIVE: This investigation analyzed clinical characteristics of patients with hypertrophic cardiomyopathy (HCM) and latent …
Characteristics and Outcomes of Elderly Patients With Hypertrophic Cardiomyopathy.
Alashi A, Smedira NG, Popovic ZB, Fava A, Thamilarasan M, Kapadia SR, Wierup P, Lever HM, Desai MY. Alashi A, et al. J Am Heart Assoc. 2021 Feb 2;10(3):e018527. doi: 10.1161/JAHA.120.018527. Epub 2021 Jan 28. J Am Heart Assoc. 2021. PMID: 33506683 Free PMC article.
Background We report characteristics and outcomes of elderly patients with hypertrophic cardiomyopathy (HCM) with basal septal hypertrophy and dynamic left ventricular outflow tract obstruction. ...The primary outcome was death and appropriate internal defibrillator …
Background We report characteristics and outcomes of elderly patients with hypertrophic cardiomyopathy (HCM) with basal septal …
The sex gap in hypertrophic cardiomyopathy.
Montenegro Sá F, Oliveira M, Belo A, Correia J, Azevedo O, Morais J; Portuguese Registry of Hypertrophic Cardiomyopathy investigators. Montenegro Sá F, et al. Rev Esp Cardiol (Engl Ed). 2020 Dec;73(12):1018-1025. doi: 10.1016/j.rec.2020.01.007. Epub 2020 Feb 28. Rev Esp Cardiol (Engl Ed). 2020. PMID: 32115394 English, Spanish.
INTRODUCTION AND OBJECTIVES: Key sex differences have been explored in multiple cardiac conditions. However, sex impact in hypertrophic cardiomyopathy outcome is unclear. We aimed to characterize sex impact in overall and cardiovascular (CV) mortality in a nationwid …
INTRODUCTION AND OBJECTIVES: Key sex differences have been explored in multiple cardiac conditions. However, sex impact in hypertrophic …
1,371 results